Insufficient scRNA-seq data for expression of RNF182 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 1153.91 | 2613 / 2642 | 98% | 24.25 | 688 / 705 |
thymus | 86% | 137.22 | 559 / 653 | 37% | 1.94 | 221 / 605 |
lung | 99% | 528.83 | 573 / 578 | 16% | 1.46 | 188 / 1155 |
ovary | 22% | 33.01 | 39 / 180 | 70% | 7.27 | 302 / 430 |
kidney | 57% | 121.13 | 51 / 89 | 33% | 2.24 | 296 / 901 |
skin | 23% | 52.14 | 416 / 1809 | 61% | 10.54 | 289 / 472 |
adipose | 73% | 137.88 | 882 / 1204 | 0% | 0 | 0 / 0 |
breast | 45% | 59.78 | 206 / 459 | 12% | 1.49 | 133 / 1118 |
uterus | 18% | 31.49 | 30 / 170 | 31% | 6.06 | 140 / 459 |
peripheral blood | 26% | 85.41 | 244 / 929 | 0% | 0 | 0 / 0 |
bladder | 5% | 4.33 | 1 / 21 | 20% | 1.79 | 100 / 504 |
prostate | 23% | 32.77 | 57 / 245 | 0% | 0.03 | 2 / 502 |
intestine | 5% | 5.22 | 48 / 966 | 13% | 0.99 | 71 / 527 |
pancreas | 11% | 13.59 | 37 / 328 | 6% | 1.02 | 11 / 178 |
stomach | 2% | 1.98 | 8 / 359 | 13% | 1.89 | 37 / 286 |
esophagus | 5% | 5.96 | 75 / 1445 | 9% | 1.09 | 17 / 183 |
adrenal gland | 1% | 2.21 | 3 / 258 | 10% | 0.62 | 24 / 230 |
tonsil | 0% | 0 | 0 / 0 | 7% | 1.36 | 3 / 45 |
spleen | 6% | 13.54 | 15 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 6% | 8.01 | 78 / 1335 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 4% | 0.25 | 15 / 406 |
heart | 4% | 4.41 | 31 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.11 | 2 / 80 |
muscle | 1% | 1.71 | 12 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RNF182 |
Protein name | Ring finger protein 182 E3 ubiquitin-protein ligase RNF182 (EC 2.3.2.27) (RING finger protein 182) (RING-type E3 ubiquitin transferase RNF182) |
Synonyms | |
Description | FUNCTION: E3 ubiquitin-protein ligase that mediates the ubiquitination of ATP6V0C and targets it to degradation via the ubiquitin-proteasome pathway . Also plays a role in the inhibition of TLR-triggered innate immune response by mediating 'Lys'-48-linked ubiquitination and subsequent degradation of NF-kappa-B component RELA . . |
Accessions | C9IZ30 ENST00000544682.5 ENST00000488763.5 C9JAJ3 ENST00000471906.1 ENST00000537663.5 C9JVS8 Q8N6D2 ENST00000488300.6 ENST00000537388.1 ENST00000420478.2 C9JAK6 ENST00000423553.6 |